Serum microRNA-29 levels correlate with disease progression in patients with chronic hepatitis B virus infection

Journal of Digestive Diseases

Volumn 15, Issue 11, 2014, Pages 614-621

  Huang, Chong ^a   Zheng, Jian Ming ^a   Cheng, Qi ^a   Yu, Kang Kang ^a   Ling, Qing Xia ^a   Chen, Ming Quan ^a   Li, Ning ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Biomarker; Chronic hepatitis B; Hepatitis B virus; Liver fibrosis; MicroRNAs

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; MICRORNA 29; MICRORNA 29A; MICRORNA 29B; MICRORNA 29C; UNCLASSIFIED DRUG; HEPATITIS B ANTIGEN; MICRORNA; MIRN29 MICRORNA, HUMAN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; LEUKOCYTE COUNT; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; THROMBOCYTE COUNT; VIRUS LOAD; ADOLESCENT; BLOOD; CASE CONTROL STUDY; GENETICS; LIVER; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HEPATITIS B ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; LEUKOCYTE COUNT; LIVER; LIVER CIRRHOSIS; MALE; MICRORNAS; MIDDLE AGED; PLATELET COUNT; YOUNG ADULT;

EID: 84912016265     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.12185     Document Type: Article

References (29)

1. Dienstag JL. Hepatitis B virus infection. N Engl J Med 2008; 359: 1486-1500.
2. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology 2009; 49: S45-55.
3. Degertekin B, Lok AS. Indications for therapy in hepatitis B. Hepatology 2009; 49: S129-137.
4. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
5. Song G, Jia H, Xu H etal. Studying the association of microRNA-210 level with chronic hepatitis B progression. J Viral Hepat 2014; 21: 272-280.
6. Zou C, Li Y, Cao Y etal. Up-regulated MicroRNA-181a induces carcinogenesis in hepatitis B virus-related hepatocellular carcinoma by targeting E2F5. BMC Cancer 2014; 14: 97.
7. Cui M, Wang Y, Sun B, Xiao Z, Ye L, Zhang X. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA. Biochem Biophys Res Commun 2014; 444: 270-275.
8. Wu CS, Yen CJ, Chou RH etal. Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression. Int J Cancer 2014; 134: 1638-1647.
9. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 2010; 285: 17442-17452.
10. Schwarzenbach H, Nishida N, Calin GA, Pantel K. Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol 2014; 11: 145-156.
11. Grasedieck S, Sorrentino A, Langer C etal. Circulating microRNAs in hematological diseases: principles, challenges, and perspectives. Blood 2013; 121: 4977-4984.
12. Waidmann O, Bihrer V, Pleli T etal. Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection. J Viral Hepat 2012; 19: e58-65.
13. He Y, Huang C, Lin X, Li J. MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases. Biochimie 2013; 95: 1355-1359.
14. Wang Y, Zhang X, Li H, Yu J, Ren X. The role of miRNA-29 family in cancer. Eur J Cell Biol 2013; 92: 123-128.
15. Moreira RK. Hepatic stellate cells and liver fibrosis. Arch Pathol Lab Med 2007; 131: 1728-1734.
16. Roderburg C, Urban GW, Bettermann K etal. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011; 53: 209-218.
17. Sekiya Y, Ogawa T, Yoshizato K, Ikeda K, Kawada N. Suppression of hepatic stellate cell activation by microRNA-29b. Biochem Biophys Res Commun 2011; 412: 74-79.
18. Tiao MM, Wang FS, Huang LT etal. MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway. Apoptosis 2014; 19: 30-41.
19. Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B (2010 version). Chin J Hepatol 2011; 19: 13-24 (in Chinese).
20. Chen CF, Lee WC, Yang HI etal.; Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer in HBV (REVEAL-HBV) Study Group. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma. Gastroenterology 2011; 141: 1240-1248.e2.
21. Tai DI, Lin SM, Sheen IS, Chu CM, Lin DY, Liaw YF. Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time. Hepatology 2009; 49: 1859-1867.
22. Arataki K, Hayes CN, Akamatsu S etal. Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B. J Med Virol 2013; 85: 789-798.
23. Pirola CJ, Fernández Gianotti T, Castaño GO etal. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histololgy and disease pathogenesis. Gut 2014 Jun 27. pii: gutjnl-2014-306996. [Epub ahead of print].
24. Shrivastava S, Petrone J, Steele R, Lauer GM, Di Bisceglie AM, Ray RB. Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression. Hepatology 2013; 58: 863-871.
25. Waidmann O, Köberle V, Brunner F, Zeuzem S, Piiper A, Kronenberger B. Serum microRNA-122 predicts survival in patients with liver cirrhosis. PLoS One 2012; 7: e45652.
26. Boon RA, Vickers KC. Intercellular transport of microRNAs. Arterioscler Thromb Vasc Biol 2013; 33: 186-192.
27. Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 2012; 110: 483-495.
28. Brain O, Owens BM, Pichulik T etal. The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release. Immunity 2013; 39: 521-536.
29. Bandyopadhyay S, Friedman RC, Marquez RT etal. Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. J Infect Dis 2011; 203: 1753-1762.